Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis
/PRNewswire/ -- Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:...
Source: prnewswire.com